Actively Recruiting
Subclinical Atrial Fibrillation Home Monitoring in Hypertensive Patients
Led by Cardiovascular Research Center Rosario British Sanatorium · Updated on 2025-07-10
499
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Atrial fibrillation is a highly prevalent and incidental arrhythmia, often asymptomatic, and frequently detected incidentally or in association with a stroke. Subclinical atrial fibrillation increases cardioembolic risk, highlighting the need for timely diagnosis. New wireless devices capable of recording heart rhythm, combined with innovative artificial intelligence tools, could be useful in the prediction and detection of this arrhythmia. Objective: to determine the usefulness of home blood pressure and heart rhythm monitoring strategy in the detection of subclinical atrial fibrillation. Methods: observational, cohort, prospective, multicenter study involving 25 researchers from six Latin American countries. Home blood pressure monitoring and single-lead electrocardiogram recording were performed in a population at moderate to high risk of developing atrial fibrillation. A minimum of twenty 30-second electrocardiographic and blood pressure recordings over 7 days using an Omron Complete Hem-7530 T ECG device will be uploaded from a mobile phone app and then sent to a database for analysis. Conclusions: the results of this study can provide a simple and accessible home monitoring system for detecting subclinical atrial fibrillation and for optimizing the predictive capacity of arrhythmia risk scores through deep learning.
CONDITIONS
Official Title
Subclinical Atrial Fibrillation Home Monitoring in Hypertensive Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hypertensive patients over 75 years of age
- Hypertensive patients aged 65 to 75 with at least one of the following: obesity, type 2 diabetes, obstructive sleep apnea syndrome, left ventricular hypertrophy on ECG or echocardiogram, left atrial dilation, coronary artery disease, chronic kidney disease, heart failure with ejection fraction over 50%, alcohol intake, or frequent supraventricular ectopic beats
You will not qualify if you...
- History of any type of atrial fibrillation
- Taking medications that may affect heart rhythm
- History of potentially dangerous ventricular arrhythmias
- Uncontrolled hypothyroidism or hyperthyroidism
- Significant chronic obstructive pulmonary disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
British Sanatorium Cardiovascular Research Center
Rosario, Santa Fe Province, Argentina, 2000
Actively Recruiting
Research Team
D
Daniel L Piskorz, MD
CONTACT
R
Ricardo López Santi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here